These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21131273)

  • 1. Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease.
    Westra J; de Groot L; Plaxton SL; Brouwer E; Posthumus MD; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2011 Apr; 50(4):665-73. PubMed ID: 21131273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis.
    López-Mejías R; Corrales A; Genre F; Hernández JL; Ochoa R; Blanco R; González-Juanatey C; Martín J; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2013; 31(5):761-6. PubMed ID: 23899926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
    de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
    Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis.
    Kurosaka D; Hirai K; Nishioka M; Miyamoto Y; Yoshida K; Noda K; Ukichi T; Yanagimachi M; Furuya K; Takahashi E; Kingetsu I; Fukuda K; Yamada A
    J Rheumatol; 2010 Jun; 37(6):1121-8. PubMed ID: 20436077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
    Knudsen LS; Klarlund M; Skjødt H; Jensen T; Ostergaard M; Jensen KE; Hansen MS; Hetland ML; Nielsen HJ; Johansen JS
    J Rheumatol; 2008 Jul; 35(7):1277-87. PubMed ID: 18597410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
    Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA.
    Erlandsson MC; Forslind K; Andersson SE; Lund A; Bokarewa MI
    Rheumatology (Oxford); 2012 May; 51(5):932-40. PubMed ID: 22258387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction.
    Clavel G; Bessis N; Lemeiter D; Fardellone P; Mejjad O; Ménard JF; Pouplin S; Boumier P; Vittecoq O; Le Loët X; Boissier MC
    Clin Immunol; 2007 Aug; 124(2):158-64. PubMed ID: 17560831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.
    Myasoedova E; Chandran A; Ilhan B; Major BT; Michet CJ; Matteson EL; Crowson CS
    Ann Rheum Dis; 2016 Mar; 75(3):560-5. PubMed ID: 25637001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
    Ajeganova S; Andersson ML; Frostegård J; Hafström I
    J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
    Kapetanovic MC; Lindqvist E; Simonsson M; Geborek P; Saxne T; Eberhardt K
    Scand J Rheumatol; 2010; 39(5):353-9. PubMed ID: 20615160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vascular endothelial growth factor in late rheumatoid arthritis.
    Pinheiro GR; Andrade CA; Gayer CR; Coelho MS; Freire SM; Scheinberg MA
    Clin Exp Rheumatol; 2001; 19(6):721-3. PubMed ID: 11791646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.
    de Groot L; Hinkema H; Westra J; Smit AJ; Kallenberg CG; Bijl M; Posthumus MD
    Arthritis Res Ther; 2011; 13(6):R205. PubMed ID: 22168993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
    Dessein PH; Joffe BI; Singh S
    Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
    Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
    Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.